跳至主要内容
临床试验/NCT04064489
NCT04064489已完成不适用

Thromboembolic Risk Stratification by TRIP Score (Cast) to Guide Physicians in Preventive Treatment Prescriptions for Patients With Lower Limb Trauma Requiring Brace or Casting.

University Hospital, Angers16 个研究点 分布在 2 个国家目标入组 2,123 人开始时间: 2020年6月16日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
2,123
试验地点
16
主要终点
Rate of symptomatic venous thromboembolic events (deep vein thrombosis and / or pulmonary embolism) among patients with a TRiP(cast) score < 7

研究概览

简要总结

Non-surgical traumas to the lower limbs that require orthopedic immobilisation (plaster or splint) are a frequent reason for going to accident and emergency. Due to venous stasis caused by immobilisation, hypercoagulable states and vascular injuries brought on by the trauma, these patients are at risk of developing VTE. For this reason, it is current practice in France and Belgium for the majority of patients to receive a preventative anticoagulant treatment. However, the benefit of this treatment, which has a considerable cost, is controversial. Contrary to French recommendations, American recommendations from 2012 actually advise against systematic preventative medicine, with prevention appearing to be effective primarily in studies with restrictive inclusion criteria. The most significant randomised controlled study on the subject did not show the benefit of low-molecular-weight heparin (LMWH) on the rate of symptomatic VTE among 1,435 non-selected patients. Therefore, in 2017, the Cochrane meta-analysis concluded that stratification of the risk of thromboembolism is required.

For this purpose, in collaboration with the Dutch team of Nemeth et al. we have recently developed a risk stratification model that takes into consideration the patient's characteristics, the type of immobilisation and the severity of the trauma: the TRiP(cast) score. This score is applied retrospectively to a large cohort and demonstrates excellent prognostic performances (AUC (area under the curve) of 0.74). In addition, when using a <7 limits, it makes it possible to identify a large group of patients at very low risk of developing VTE (negative predictive value: 99.2%).

The aim of the CASTING study is to prospectively demonstrate the reliability and utility of the TRiP(cast) score by showing that patients with orthopaedic immobilisation of a lower limb who are not receiving preventative treatment on the basis of a TRiP(cast) score of <7 have a very low rate of symptomatic VTE, which allows for a significant reduction in prescriptions of anticoagulants in comparison with prior practices.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Sequential
主要目的
Prevention
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Consultation in one of the emergency department participating in the study,
  • Isolated trauma from lower limb,
  • Rigid (plaster or resin) or semi-rigid immobilization for an assumed duration of at least 7 days,
  • Adults (18 years),
  • Affiliated patient or beneficiary of a social security,
  • Patient with prior informed consent.

排除标准

  • Patient with anticoagulant treatment at the time of trauma,
  • Trauma requiring hospitalization of more than 48 hours,
  • Co-morbidity(s) requiring hospitalization of more than 48 hours at the time of inclusion,
  • Any factor making 90-day follow-up impossible,
  • Pregnant, nursing or childbearing patient,
  • Patient deprived of liberty by judicial or administrative decision,
  • Patient undergoing psychiatric care under duress,
  • Patient subject to a legal protection measure,
  • Patient unable to give free and informed consent.

结局指标

主要结局

Rate of symptomatic venous thromboembolic events (deep vein thrombosis and / or pulmonary embolism) among patients with a TRiP(cast) score < 7

时间窗: Day 90

To demonstrate the reliability and safety of the decision not to implement thromboprophylaxis in patients with orthopedic immobilization for lower extremity trauma and Trip(cast) \< 7

次要结局

  • Rate of symptomatic venous thromboembolic events (deep vein thrombosis and / or pulmonary embolism) (whole population)(Day 90)
  • Rate of prescription for thromboprophylaxis(Day 1)
  • Physicians' satisfaction using likert's scale(Day 1)
  • The rate of complications of preventive anticoagulant treatment (bleeding)(Day 90)
  • The direct cost of preventive anticoagulant treatment when the TRiP(cast) score is applied compared to current practices(Day 90)

研究者

发起方
University Hospital, Angers
申办方类型
Other Gov
责任方
Sponsor

研究点 (16)

Loading locations...

相似试验